Study Reveals Decades of Genetic Adaptation Behind Global Superbug Threat

A recent study has uncovered the genetic mechanisms that allowed one of the world’s most dangerous antibiotic-resistant bacteria to quietly infiltrate hospitals and dominate the global epidemiological landscape.

The international research team, led by the University of East Anglia in the UK and including scientists from the Quadram Institute in Britain as well as universities in Canada and Mexico, analyzed laboratory samples dating back to the 1970s. Their goal was to reconstruct the genetic history of Acinetobacter baumannii, a persistent hospital pathogen notorious for its extreme resistance to treatment.

The researchers discovered that this bacterium did not emerge suddenly as a superbug threat. Instead, it evolved and adapted gradually over several decades through small but cumulative genetic changes that eventually enabled it to withstand most available antibiotics.

Dr. Benjamin Evans, the lead investigator from the Norwich Medical School at the University of East Anglia, explained that bacteria causing human infections can adapt to antibiotics, rendering these drugs ineffective. He noted that their focus on this particular species was due to its ability to thrive in hospital environments and cause infections that are especially difficult to treat in vulnerable patients.

He added that understanding how this microbe transformed into such a significant threat is crucial for halting its spread, although the genetic events behind its success had remained unclear until now.

The study revealed that the bacterium evolved in successive waves, with each new wave producing strains increasingly capable of resisting antibiotics compared to previous ones. This provides one of the clearest scientific illustrations of how resistance accumulates gradually before tipping the balance suddenly in favor of the pathogen.

The researchers emphasized that this superbug was effectively “manufactured” over decades and continues to evolve.

To achieve these insights, the team assembled a unique collection of 226 bacterial samples from the 1970s through the early 2000s. They cultured these samples in the laboratory, extracted their DNA, and sequenced it using advanced Oxford Nanopore technology.

For a comprehensive global perspective, the scientists combined these historical genomes with over a thousand modern genomes from six continents. They compared a total of 1,281 chromosomes, enabling them to construct a detailed evolutionary tree and conduct an extensive survey of antibiotic resistance genes to track their emergence, disappearance, and reshaping over time.

By correlating genetic changes with the dates and locations of the samples, the researchers identified when key resistance traits appeared and how they spread worldwide. They concluded that the bacterium did not suddenly appear as a superbug, but gradually infiltrated and dominated until by 2005 it had become the most widespread strain of its kind globally.

A critical turning point was identified when the bacterium acquired two major genetic elements, including a gene called oxa23. This gene confers resistance to powerful antibiotics, enhancing the bacterium’s ability to survive treatments and complicating efforts to eradicate it.

The study also found that Acinetobacter baumannii is not a single uniform strain but divides into at least four distinct groups, each following its own evolutionary path. Three of these groups showed gradual, stepwise evolution resembling a slow genetic arms race against modern medicine. The fourth group stands out as different, appearing to have branched off independently and increasingly detected in recent samples. This raises concerns that a newer, potentially more adapted variant may be emerging.

The researchers stressed the importance of these findings in guiding current and future antibiotic use policies, especially regarding bacteria like Acinetobacter baumannii that pose serious threats to global health systems. They warned of an urgent need to develop new strategies to combat these pathogens, or else the infections they cause could become untreatable.